Rep. Paul Frost

Maddy summaryHD 2235 creates a commission to study ways to increase voluntary organ donation in Massachusetts, directly affecting the state's organ donation system and potential future policy. The commission, composed of legislative leaders, health officials, and department representatives, will examine incentives - including monetary programs used in other states - to boost donation rates. It must assess existing state and out-of-state incentive models and submit recommendations with draft legislation within 12 months. The bill does not implement new policies but sets up a formal process for evaluating potential changes to organ donation programs.

Maddy summaryHD 3737 establishes a commission to study direct primary care services in Massachusetts, where patients pay doctors directly for care without insurance involvement. The commission will examine benefits like lower costs, cost transparency, better access to care, and improved health outcomes, then develop strategies to promote these services. Composed of state health officials, legislative leaders, healthcare industry representatives, and patient advocates, the commission must hold at least three public hearings and submit a report with recommendations within 12 months. This bill does not change current law but creates a study to inform future policy decisions about expanding direct primary care. The commission's work aims to ease pressure on the healthcare system and improve patient access.

Maddy summaryThis bill requires general acute care hospitals in Massachusetts to include fentanyl testing in standard urine drug screenings when treating patients for diagnosis. It directly affects hospitals that conduct such screenings, mandating they test for fentanyl alongside other drugs like opioids and cocaine. The key provision specifies that "urine drug screening" must now include fentanyl, with the Department of Public Health authorized to create necessary regulations for implementation. This policy change aims to improve detection of fentanyl exposure in medical settings without altering existing screening protocols for other substances.

Maddy summaryThis bill establishes a state-wide program to collect and redistribute unused, unopened, tamper-evident medicines from authorized donors (like pharmacies, hospitals, and manufacturers) to eligible patients who are indigent, uninsured, underinsured, or enrolled in public health programs. Donated medicines must be in unopened packaging (with limited exceptions for certain orally administered cancer medicines), not controlled substances, and meet safety standards like proper storage and labeling. Recipients must verify donor eligibility and maintain minimal records but can store donated medicine separately, repackage it as needed, and administer it to eligible patients with proper documentation. The program aims to reduce medicine waste while expanding access to affordable medications for vulnerable populations.

Maddy summaryThis bill requires restaurants and other food-serving establishments to clearly identify common food allergens in English on menus or visible allergen lists. It specifically mandates listing ingredients containing milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, or soybeans, either in ingredient lists or with a "contains" statement next to menu items. The allergen information must be readily available to customers through menus, separate lists, or posted signs. The Department of Public Health may adjust these requirements as needed.

Maddy summaryThis bill gradually eliminates the inventory tax on business property in Massachusetts. It reduces the tax rate from $2.60 per $100 of inventory value to $0.50 over multiple steps, with final implementation by 2030. The key mechanism shifts the tax from a flat rate to a declining percentage of net income (starting at 9.5% for 2020-2021 and decreasing to 8.0% for 2022+). These changes directly affect businesses that pay the inventory tax, primarily commercial entities holding physical inventory. The phased approach spans from 2026 through 2030, with specific effective dates for each rate reduction step.

Maddy summaryThis bill (HD 1327) requires a 3-month waiting period before any new tax can be collected after legislation creating that tax is passed. It directly affects all new taxes established by state law, including those proposed in bills or amendments. The key provision states that no new tax may be collected, assessed, or payable until 90 days after the bill creating it becomes law. This delays implementation but does not change tax rates or create new taxes. The bill applies to all new tax measures, not existing ones.

Maddy summaryHD 1336 requires Massachusetts state agencies to give preference to vendors with cybersecurity insurance when buying information technology goods or services. This applies specifically to IT procurement contracts, meaning agencies must prioritize bids from vendors holding such insurance. However, the bill explicitly states that vendors without cybersecurity insurance can still submit bids and be awarded contracts - they are simply not given priority. The law aims to encourage stronger cybersecurity practices among vendors working with state agencies without banning uninsured vendors entirely.

By Ms. Lovely, a petition (accompanied by bill, Senate, No. 1573) of Joan B. Lovely, Jason M. Lewis, Paul K. Frost, Ryan C. Fattman and other members of the General Court for legislation relative to newborn screenings for congenital cytomegalovirus. Public Health.

Maddy summaryHD 2249 establishes a commission to study how health insurers use "preferred pharmacy networks" to steer patients toward lower-cost pharmacies where insurers negotiate better drug prices. The commission, composed of legislative leaders, health officials, and policy experts, will analyze the feasibility and cost-benefit of implementing such networks and estimate potential prescription drug savings. It must submit a report with recommendations and draft legislation to relevant committees within 12 months of the bill's passage. This bill does not change current law but creates a formal process to evaluate a specific cost-saving approach used by insurers. The direct effect is on insurers, pharmacies, and the state's health policy decision-makers.